APA-referens (7:e uppl.)

Sheng, J., Chen, H., Fu, B., Pan, H., Wang, J., & Han, W. (2024). BPI-28592 as a novel second generation inhibitor for NTRK fusion tumors. npj Precision Oncology, 8(1), 1. https://doi.org/10.1038/s41698-024-00686-8

Chicago-referens (17:e uppl.)

Sheng, Jin, Hong Chen, Bang Fu, Hongming Pan, Jiabing Wang, och Weidong Han. "BPI-28592 as a Novel Second Generation Inhibitor for NTRK Fusion Tumors." Npj Precision Oncology 8, no. 1 (2024): 1. https://doi.org/10.1038/s41698-024-00686-8.

MLA-referens (9:e uppl.)

Sheng, Jin, et al. "BPI-28592 as a Novel Second Generation Inhibitor for NTRK Fusion Tumors." Npj Precision Oncology, vol. 8, no. 1, 2024, p. 1, https://doi.org/10.1038/s41698-024-00686-8.